Biogen Idec Inc. said Monday that CEO James C. Mullen will retire June 8 and the biotechnology company has started a search for his successor.
Mullen, 51, will also retire from the company's board of directors when his term expires in 2010.
Shares of Biogen rose 14 cents to close at $53.64.
© Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.